Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

AMG510 (sotorasib) Plus Lenvatinib As Second-line Treatment in Patients with KRASG12C Mutant, Metastatic NSCLC

ETOP IBCSG Partners Foundation · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
metastatic non small cell lung cancer, kras g12c, metastatic nsclc, sotorasib, lenvatinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 859639
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.